Gastrointestinal bleeding is also known as gastrointestinal hemorrhage. It includes all forms of bleeding of gastrointestinal tract, from the mouth to the rectum. Endoscopic hemostatic devices are the primary line of treatment for gastrointestinal bleeding. The major endoscopic hemostatic devices include thermal and mechanical.
According to this study, over the next five years the Gastrointestinal Bleeding Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Gastrointestinal Bleeding Treatment business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal Bleeding Treatment market by product type, application, key manufacturers and key regions and countries.
This study considers the Gastrointestinal Bleeding Treatment value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Endoscopic Hemostatic Devices
Closure Devices
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Ambulatory Surgical Centers
Clinics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Boston Scientific
Olympus
CONMED
Cook Medical
Ovesco Endoscopy
Erbe Elektromedizin
STERIS
US Medical Innovations
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Gastrointestinal Bleeding Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Gastrointestinal Bleeding Treatment market by identifying its various subsegments.
Focuses on the key global Gastrointestinal Bleeding Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Gastrointestinal Bleeding Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Gastrointestinal Bleeding Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
2019-2024 Global Gastrointestinal Bleeding Treatment Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gastrointestinal Bleeding Treatment Consumption 2014-2024
2.1.2 Gastrointestinal Bleeding Treatment Consumption CAGR by Region
2.2 Gastrointestinal Bleeding Treatment Segment by Type
2.2.1 Endoscopic Hemostatic Devices
2.2.2 Closure Devices
2.3 Gastrointestinal Bleeding Treatment Consumption by Type
2.3.1 Global Gastrointestinal Bleeding Treatment Consumption Market Share by Type (2014-2019)
2.3.2 Global Gastrointestinal Bleeding Treatment Revenue and Market Share by Type (2014-2019)
2.3.3 Global Gastrointestinal Bleeding Treatment Sale Price by Type (2014-2019)
2.4 Gastrointestinal Bleeding Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Centers
2.4.3 Clinics
2.5 Gastrointestinal Bleeding Treatment Consumption by Application
2.5.1 Global Gastrointestinal Bleeding Treatment Consumption Market Share by Application (2014-2019)
2.5.2 Global Gastrointestinal Bleeding Treatment Value and Market Share by Application (2014-2019)
2.5.3 Global Gastrointestinal Bleeding Treatment Sale Price by Application (2014-2019)
3 Global Gastrointestinal Bleeding Treatment by Manufacturers
3.1 Global Gastrointestinal Bleeding Treatment Sales Market Share by Manufacturers
3.1.1 Global Gastrointestinal Bleeding Treatment Sales by Manufacturers (2017-2019)
3.1.2 Global Gastrointestinal Bleeding Treatment Sales Market Share by Manufacturers (2017-2019)
3.2 Global Gastrointestinal Bleeding Treatment Revenue Market Share by Manufacturers
3.2.1 Global Gastrointestinal Bleeding Treatment Revenue by Manufacturers (2017-2019)
3.2.2 Global Gastrointestinal Bleeding Treatment Revenue Market Share by Manufacturers (2017-2019)
3.3 Global Gastrointestinal Bleeding Treatment Sale Price by Manufacturers
3.4 Global Gastrointestinal Bleeding Treatment Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
3.4.1 Global Gastrointestinal Bleeding Treatment Manufacturing Base Distribution and Sales Area by Manufacturers
3.4.2 Players Gastrointestinal Bleeding Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Gastrointestinal Bleeding Treatment by Regions
4.1 Gastrointestinal Bleeding Treatment by Regions
4.1.1 Global Gastrointestinal Bleeding Treatment Consumption by Regions
4.1.2 Global Gastrointestinal Bleeding Treatment Value by Regions
4.2 Americas Gastrointestinal Bleeding Treatment Consumption Growth
4.3 APAC Gastrointestinal Bleeding Treatment Consumption Growth
4.4 Europe Gastrointestinal Bleeding Treatment Consumption Growth
4.5 Middle East & Africa Gastrointestinal Bleeding Treatment Consumption Growth
5 Americas
5.1 Americas Gastrointestinal Bleeding Treatment Consumption by Countries
5.1.1 Americas Gastrointestinal Bleeding Treatment Consumption by Countries (2014-2019)
5.1.2 Americas Gastrointestinal Bleeding Treatment Value by Countries (2014-2019)
5.2 Americas Gastrointestinal Bleeding Treatment Consumption by Type
5.3 Americas Gastrointestinal Bleeding Treatment Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Gastrointestinal Bleeding Treatment Consumption by Countries
6.1.1 APAC Gastrointestinal Bleeding Treatment Consumption by Countries (2014-2019)
6.1.2 APAC Gastrointestinal Bleeding Treatment Value by Countries (2014-2019)
6.2 APAC Gastrointestinal Bleeding Treatment Consumption by Type
6.3 APAC Gastrointestinal Bleeding Treatment Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Gastrointestinal Bleeding Treatment by Countries
7.1.1 Europe Gastrointestinal Bleeding Treatment Consumption by Countries (2014-2019)
7.1.2 Europe Gastrointestinal Bleeding Treatment Value by Countries (2014-2019)
7.2 Europe Gastrointestinal Bleeding Treatment Consumption by Type
7.3 Europe Gastrointestinal Bleeding Treatment Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Gastrointestinal Bleeding Treatment by Countries
8.1.1 Middle East & Africa Gastrointestinal Bleeding Treatment Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Gastrointestinal Bleeding Treatment Value by Countries (2014-2019)
8.2 Middle East & Africa Gastrointestinal Bleeding Treatment Consumption by Type
8.3 Middle East & Africa Gastrointestinal Bleeding Treatment Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Gastrointestinal Bleeding Treatment Distributors
10.3 Gastrointestinal Bleeding Treatment Customer
11 Global Gastrointestinal Bleeding Treatment Market Forecast
11.1 Global Gastrointestinal Bleeding Treatment Consumption Forecast (2019-2024)
11.2 Global Gastrointestinal Bleeding Treatment Forecast by Regions
11.2.1 Global Gastrointestinal Bleeding Treatment Forecast by Regions (2019-2024)
11.2.2 Global Gastrointestinal Bleeding Treatment Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Gastrointestinal Bleeding Treatment Forecast by Type
11.8 Global Gastrointestinal Bleeding Treatment Forecast by Application
12 Key Players Analysis
12.1 Boston Scientific
12.1.1 Company Details
12.1.2 Gastrointestinal Bleeding Treatment Product Offered
12.1.3 Boston Scientific Gastrointestinal Bleeding Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Boston Scientific News
12.2 Olympus
12.2.1 Company Details
12.2.2 Gastrointestinal Bleeding Treatment Product Offered
12.2.3 Olympus Gastrointestinal Bleeding Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Olympus News
12.3 CONMED
12.3.1 Company Details
12.3.2 Gastrointestinal Bleeding Treatment Product Offered
12.3.3 CONMED Gastrointestinal Bleeding Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 CONMED News
12.4 Cook Medical
12.4.1 Company Details
12.4.2 Gastrointestinal Bleeding Treatment Product Offered
12.4.3 Cook Medical Gastrointestinal Bleeding Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Cook Medical News
12.5 Ovesco Endoscopy
12.5.1 Company Details
12.5.2 Gastrointestinal Bleeding Treatment Product Offered
12.5.3 Ovesco Endoscopy Gastrointestinal Bleeding Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Ovesco Endoscopy News
12.6 Erbe Elektromedizin
12.6.1 Company Details
12.6.2 Gastrointestinal Bleeding Treatment Product Offered
12.6.3 Erbe Elektromedizin Gastrointestinal Bleeding Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Erbe Elektromedizin News
12.7 STERIS
12.7.1 Company Details
12.7.2 Gastrointestinal Bleeding Treatment Product Offered
12.7.3 STERIS Gastrointestinal Bleeding Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 STERIS News
12.8 US Medical Innovations
12.8.1 Company Details
12.8.2 Gastrointestinal Bleeding Treatment Product Offered
12.8.3 US Medical Innovations Gastrointestinal Bleeding Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 US Medical Innovations News
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Gastrointestinal Bleeding Treatment
Table Product Specifications of Gastrointestinal Bleeding Treatment
Figure Gastrointestinal Bleeding Treat